CAA and related co‐morbidities in Down syndrome and Alzheimer disease

2021 ◽  
Vol 17 (S2) ◽  
Author(s):  
Amisha Kumar ◽  
Eric Doran ◽  
Alessandra Cadete Martini ◽  
Elizabeth Head ◽  
Kate Kirby
2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Christina N. Lessov-Schlaggar ◽  
Olga L. del Rosario ◽  
John C. Morris ◽  
Beau M. Ances ◽  
Bradley L. Schlaggar ◽  
...  

Abstract Background Adults with Down syndrome (DS) are at increased risk for Alzheimer disease dementia, and there is a pressing need for the development of assessment instruments that differentiate chronic cognitive impairment, acute neuropsychiatric symptomatology, and dementia in this population of patients. Methods We adapted a widely used instrument, the Clinical Dementia Rating (CDR) Scale, which is a component of the Uniform Data Set used by all federally funded Alzheimer Disease Centers for use in adults with DS, and tested the instrument among 34 DS patients recruited from the community. The participants were assessed using two versions of the modified CDR—a caregiver questionnaire and an in-person interview involving both the caregiver and the DS adult. Assessment also included the Dementia Scale for Down Syndrome (DSDS) and the Raven’s Progressive Matrices to estimate IQ. Results Both modified questionnaire and interview instruments captured a range of cognitive impairments, a majority of which were found to be chronic when accounting for premorbid function. Two individuals in the sample were strongly suspected to have early dementia, both of whom had elevated scores on the modified CDR instruments. Among individuals rated as having no dementia based on the DSDS, about half showed subthreshold impairments on the modified CDR instruments; there was substantial agreement between caregiver questionnaire screening and in-person interview of caregivers and DS adults. Conclusions The modified questionnaire and interview instruments capture a range of impairment in DS adults, including subthreshold symptomatology, and the instruments provide complementary information relevant to the ascertainment of dementia in DS. Decline was seen across all cognitive domains and was generally positively related to age and negatively related to IQ. Most importantly, adjusting instrument scores for chronic, premorbid impairment drastically shifted the distribution toward lower (no impairment) scores.


2019 ◽  
Vol 79 (7) ◽  
pp. 716-737 ◽  
Author(s):  
María Carmona‐Iragui ◽  
Laura Videla ◽  
Alberto Lleó ◽  
Juan Fortea

2001 ◽  
Vol 125 (4) ◽  
pp. 489-492 ◽  
Author(s):  
Kymberly A. Gyure ◽  
Robert Durham ◽  
Walter F. Stewart ◽  
John E. Smialek ◽  
Juan C. Troncoso

Abstract Context.—Down syndrome patients who live to middle age invariably develop the neuropathologic features of Alzheimer disease, providing a unique situation in which to study the early and sequential development of these changes. Objective.—To study the development of amyloid deposits, senile plaques, astrocytic and microglial reactions, and neurofibrillary tangles in the brains of young individuals (<30 years of age) with Down syndrome. Methods.—Histologic and immunocytochemical study of a series of autopsy brains (n = 14, from subjects aged 11 months to 56 years, with 9 subjects <30 years) examined at the Office of the Chief Medical Examiner of the State of Maryland and The Johns Hopkins Hospital. Results.—The principal observations included the presence of intraneuronal Aβ immunostaining in the hippocampus and cerebral cortex of very young Down syndrome patients (preceding the extracellular deposition of Aβ) and the formation of senile plaques and neurofibrillary tangles. Conclusions.—We propose the following sequence of events in the development of neuropathologic changes of Alzheimer disease in Down syndrome: (1) intracellular accumulation of Aβ in neurons and astrocytes, (2) deposition of extracellular Aβ and formation of diffuse plaques, and (3) development of neuritic plaques and neurofibrillary tangles with activation of microglial cells.


2002 ◽  
Vol 59 (7) ◽  
pp. 1133 ◽  
Author(s):  
Ira T. Lott ◽  
Kathryn Osann ◽  
Eric Doran ◽  
Linda Nelson

2009 ◽  
Vol 66 (12) ◽  
Author(s):  
Carol F. Lippa ◽  
Andrea L. Rosso ◽  
Lauren D. Stutzbach ◽  
Manuela Neumann ◽  
Virginia M.-Y. Lee ◽  
...  

2019 ◽  
Vol 30 (2) ◽  
pp. 319-331 ◽  
Author(s):  
Julie C. Lauterborn ◽  
Conor D. Cox ◽  
See Wing Chan ◽  
Peter W. Vanderklish ◽  
Gary Lynch ◽  
...  

2017 ◽  
Vol 13 (7S_Part_23) ◽  
pp. P1125-P1125
Author(s):  
Fabian O. Arenas Rios ◽  
Laura Diaz-Marugan ◽  
Maria Rodriguez-Peiris ◽  
Carmen Garcia-Ruiz ◽  
Jose Carlos Fernandez-Checa

Sign in / Sign up

Export Citation Format

Share Document